Cite
HARVARD Citation
Macedo, F. et al. (2019). Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer. Annals of surgery. 270 (3), p. . [Online].